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Background: Many disorders with plasmalogen deficiency have been reported. Replenishment or replacement of
tissue plasmalogens of these disorders would be beneficial to the patients with these disorders, but effects of
dietary plasmalogen on mammals have not been reported.
Methods: Plasmalogens were purified from chicken skin. The purified plasmalogens consisted of 96.4%
ethanolamine plasmalogen (PlsEtn), 2.4% choline plasmalogen (PlsCho) and 0.5% sphingomyelin (SM). A diet
containing 0.1% the purified plasmalogens (PlsEtn diet) was given to rats. Relative composition of phospholipids
was measured by a high performance liquid chromatography (HPLC) method that can separate intact plasmalogens
and all other phospholipid classes by a single chromatographic run.
Results: The PlsEtn diet given to Zucker diabetic fatty (ZDF) rats for 4 weeks caused decreases of plasma
cholesterol and plasma phospholipid as compared to control diet. The other routine laboratory tests of plasma
including triacylglycerol, glucose, liver and renal functions, albumin, and body weight were not different. Relative
compositions of erythrocyte PlsEtn and phosphatidylethanolamine (PE) increased, and that of phosphatidylcholine
(PC) decreased in PlsEtn diet group. The PlsEtn diet given to normal rats for 9 weeks again caused decrease of
plasma cholesterol and phospholipid, and it induced increase of relative composition of PlsEtn of the erythrocyte
membrane. The other routine laboratory tests of plasma and body weight were not different.
Conclusions: Dietary PlsEtn increases relative composition of PlsEtn of erythrocyte membranes in normal and ZDF
rats, and it causes decreases of plasma cholesterol and plasma phospholipids. Dietary PlsEtn for 9 weeks seemingly
causes no adverse effect to health of normal rats.
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Plasma phospholipidsBackground
Plasmalogens are glycereophospholipids characterized by
the presence of vinyl ether bond at the sn-1 position of
glycerol backbone and an ester bond at the sn-2 pos-
ition. The sn-1 position is most commonly linked to
C16, C18, or C18:1 fatty alcohols and the sn-2 position
typically occupied by an polyunsaturated fatty acid, spe-
cifically arachidonic acid (ARA) or docosahexaenoic acid
(DHA) [1-5]. Plasmalogens are found in almost all mam-
malian tissues and constitute about 18% of the total
phospholipids in cell membranes, with ethanolamine
plasmalogen (PlsEtn) much more abundant than choline* Correspondence: mawatari@rheology.po-jp.com
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reproduction in any medium, provided the orplasmalogen (PlsCho) except heart and skeletal muscle
[1-5]. Plasmalogens are not only structural component of
mammalian cell membrane and a reservoir for second
messengers, but also may involve membrane fusion, ion
transport and cholesterol efflux [1-5]. The vinyl ether bond
at the sn-1 position makes plasmalogens more susceptible
to oxidative stress than the corresponding ester bonded
glycerophospholipids, plasmalogens may also act as anti-
oxidants, protecting cells from oxidative stress [1-5].
Plasmalogen biosynthesis starts in peroxisome, and the
inherited human peroxisomal disorder, rhizomelic chon-
drodysplasia punctata (RCDP), shows deficiency of tissue
plasmalogens in multiple organs and causes severe disor-
ders of multiple organs such as bone, brain, lens, kidney
and heart [2-5]. These disorders of RCDP may be aal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cate importance of plasmalogens in human body. On the
other hand, secondary plasmalogen deficiency was
reported in metabolic and inflammatory disorders such
as diabetes mellitus, cardiac diseases, cancer, respiratory
diseases and Alzheimer’s disease [3,4]. Secondary plas-
malogen deficiency could result from decreased synthe-
sis and/or increased degradation of plasmalogens.
Replenishment and/or replacement of plasmalogens
would be of substantial benefit in these diseases with
plasmalogen deficiency.
Health effects of dietary phospholipids are recently
reviewed [6], and the majority of studies indicated that
dietary phospholipids have a positive impact in several
diseases without severe side effect, however, dietary plas-
malogen was not mentioned [6].
We prepared purified plasmalogens from chicken skin.
We administered a diet containing 0.1% the purified
plasmalogens to Zucker diabetic fatty (ZDF) rats and
normal rats of Wistar strain. Routine laboratory tests of
blood plasma (including total phospholipid) were done
and phospholipid composition of plasma and erythro-
cytes were analyzed.Results and discussion
The purified plasmalogens from chicken skin consisted
of 96.4% ethanolamine plasmalogen (PlsEtn), 2.6% cho-
line plasmalogen (PlsCho), 0.5% SM and 0.7% other
phospholipids by calculation on the HPLC chromato-
graphic area (Table 1, Figure 1). The retention times of
chromatographic peaks of PlsEtn and PlsCho were
accorded to those of PlsEtn and PlsCho of the rat
erythrocyte membrane (Figure 1), and the peaks disap-
peared after treatment with hydrochloric acid (HCl), in-
dicating the peaks were plasmalogens [7,8] (data are not
shown). The fatty acids of the PlsEtn composed of DHA
(22:6), ARA (20:4), oleic acid (18:1), myristic acid (14:0),Table 1 Phospholipid composition of the purified
plasmalogens and fatty acid composition of PlsEtn in the
purified plasmalogens
Phospholipid composition Fatty acid composition of PlsEtn
Fatty acid
PlsEtn 96.4% 14:0 5.4%
PlsCho 2.6% 16:0 7.1%
SM 0. 5% 18:0 3.5%




Abbreviations; PlsEtn, ethanolamine plasmalogen; PlsCho, choline
plasmalogen; SM, sphingomyelin: LPE, lysophosphatidylethanolamine.palmitic acid (16:0) and stearic acid (18:0) (Table 1),
which is in agree with that of ordinary plasmalogens
found in mammalian tissues [1-4].
The chromatogram of phospholipid analysis of the
PlsEtn diet showed a large peak of PlsEtn as compared
to the control diet, indicating that PlsEtn was actually
contained in the PlsEtn diet (Figure 2).
The diet contained 0.1 weight % the purified plasmalo-
gens (PlsEtn diet) caused a decrease of plasma phospho-
lipids as well as plasma cholesterol in ZDF rats within
4 weeks (Table 2). However, the other routine laboratory
tests of plasma including triacylglycerol (TG), glucose,
alanine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), urea nitrogen and albumin were not differ-
ent (Table 2). Body weight was also not different in the
both diet groups. Phospholipid composition of the
plasma analyzed by our HPLC method showed an in-
crease of SM in the PlsEtn diet group (Table 3). Plasma-
logens in the plasma was detected by our HPLC
method, but they were too small to evaluate changes of
plasmalogens (Table 3, Figure 3). The PlsEtn diet
induced increases of erythrocyte PlsEtn and PE, and de-
crease of erythrocyte PC (Table 4).
The same PlsEtn diet was administered to normal rats
of Wistar strain for 9 weeks. The PlsEtn diet again
caused decrease of plasma phospholipid as well as
plasma cholesterol, but the other routine laboratory tests
of plasma were not changed (Table 5). Phospholipid
composition of plasma was not different (Table 6).
Phospholipid composition of the erythrocyte membranes
showed an increase of PlsEtn and tendency to decrease
of PC in the PlsEtn diet group (Table 7).
These results show that dietary PlsEtn induces de-
crease of plasma cholesterol and plasma phospholipids
in normal rats as well as in ZDF rats. It has been known
that dietary phospholipids cause decrease of plasma
cholesterol probably due to inhibition of intestinal chol-
esterol absorption [6,9,10]. There is a report that dietary
PE, but not dietary PC, caused a decreases of phospho-
lipid, cholesterol and apolipoprotein A-1 in rat blood
plasama [11]. Thus it is indicated that ethanolamine
phospholipids, not limited to PlsEtn, induce a decrease
of plasma phospholipid. Phospholipid composition of
plasma in normal rats (Wistar rats) was not changed
after 9 weeks with the PlsEtn diet (Table 6), and the
other routine laboratory tests in plasma were not chan-
ged (Table 5). Body weight was also not different after
9 weeks of the PlsEtn diet (Table 5). These results indi-
cate that dietary PlsEtn is not bad for health of normal
rats despite the decrease of plasma phospholipids and
cholesterol. It may be interesting to note that plasma
triacylglycerol was not changed by the PlsEtn diet in




Figure 1 HPLC chromatogram of the purified plasmalogen from chicken skin. The retention times of ethanolamine plasmalogens
(PlsEtn) and choline plasmalogen (PlsCho) are accorded to those of rat erythrocyte. The other abbreviations: PE, phosphatidylethanolamine;
PC phosphatidylcholine; SM-1 and SM-2, sphingomyelin; PS, phosphatidyl serine; PI, phosphatidyl inositol.
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increases of PlsEtn and PE, and decrease of PC in the
erythrocyte membranes (Table 4). The PlsEtn diet to
Wistar rats for 9 weeks also induced increase of PlsEtn
and tendency to decrease of PC in the erythrocyteFigure 2 HPLC chromatograms of phospholipids of the control diet a
that plasmalogens (PlsEtn and PlsCho) was actually contained in the PlsEtnmembrane (Table 7). Fatty acid composition of PlsEtn +
PE showed an increase of ARA (20:4) and decrease of
oleic acid (18:1) (Table 8). The increase of ARA in the
erythrocyte membrane PlsEtn may reflect the fatty acid
composition of PlsEtn in the diet (Table 1). These resultsnd the plasmalogen diet (PlsEtn diet). The chromatogram indicate
diet. The other abbreviations: see Figure 1.
Table 2 Changes in plasma cholesterol and phospholipids






Total chol (mg/100mL) 206.3 ± 17.4 173.5 ± 15.3 p < 0.001
HDL-chol (mg/100mL) 60.3 ± 14.1 57.5 ± 9.6
LDL-chol (mg/100mL) 9.2 ± 4.4 5.1 ± 2.4 p < 0.02
TG (mg/100mL) 1267.4 ± 367.9 1244.6 ± 361.2
P-lipid (mg/100mL) 466.5 ± 35.5 409.3 ± 51.1 p < 0.01
Glucose (mg/100mL) 541.9 ± 172.8 507.5 ± 155.2
Urea N (mg/100mL) 19.6 ± 1.6 19.0 ± 2.1
AST (IU/L) 135.6 ± 94.2 126.5 ± 114.8
ALT (IU/L) 96.1 ± 57.7 88.3 ± 83.9
Albumin (g/100mL) 4.6 ± 0.3 4.5 ± 0.3
Body weightt (g) 407.5 ± 30.9 391.5 ± 40.1
Abbreviations: chol, cholesterol; HDL, high density lipoprotein; LDL, low
density lipoprotein; TG, triacylglycerol; P-lipid, phospholipid; Urea N, urea
nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase. Data
are mean ± SD.
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PlsEtn can increase relative concentration of tissue
PlsEtn.
Most of dietary glycerophospholipids may be hydro-
lyzed at the sn-2 position by pancreatic phospholipase
A2 in the intestinal lumen and then absorbed by the
enterocytes as free fatty acids and lysophospholipids
[6,12]. The presence of plasmalogen-active phospholip-
ase A2 in the small intestinal epithelium has been
reported [13]. Because plasmalogens contain vinyl ether
bond at the sn-1 position of glycerol, the lysophospholi-
pid derived from dietary plasmalogens after digestion by
phospholipase A2 is indicated to contain the vinyl ether
bond. It is known that dietary alkyl glycerols are
absorbed intact from the digestive tract without the
cleavage of the ether bond [14-18]. However, whether
the vinyl ether bond of dietary phospholipids absorbed
intact from the intestine is not certain. The vinyl ether
bond (1–0 alk-1’-enyl-sn-glycerol) is not same to etherTable 3 Plasma phospholipid composition of ZDF rats
after the PlsEtn diet for 4 weeks
Control diet (n = 10) PlsEtn diet (n = 10) t-test
PlsEtn 0.39 ± 0.31 0.56 ± 0.26
PE 0.46 ± 0.10 0.63 ± 0.22
PlsCho 0.23 ± 0.11 0.35 ± 0.10
PC 87.66 ± 1.14 86.88 ± 1.00
PI 2.53 ± 0.25 2.55 ± 0.23
SM 2.08 ± 0.47 2.67 ± 0.40 p < 0.01
LPC 5.60 ± 0.77 5.40 ± 0.84
Data are % of total phospholipids calculated from chromatographic area
detected by ELSD (mean ± SD).bond of alkyl glycerols (1-0-alkyl-sn-glycerol). The vinyl
ether bond is known to be especially sensitive to HCl
[7,8]. There is a report, by using a diet containing 10%
bovine brain phospholipids, that no degradation of plas-
malogens under in vitro conditions simulating those of
the stomach and small intestinal lumen was observed
[19], and they also reported that ingestion of 10% bovine
brain phospholipids increased plasmalogen in blood
plasma [19]. Thus it is likely that lysophospholipids
(lysoplasmalogens) containing the vinyl ether bond
derived from the dietary PlsEtn are absorbed intact from
rat intestine.
Since 1-0-alkylglycerol enter the plasmalogen biosyn-
thesis pathway downstream of the peroxisomal step,
plasmalogen replacement therapy for inherited peroxi-
somal disorders by using dietary 1–0 alkylglycerols are
reported and the therapy induced increases of plasmalo-
gens in several tissues [15-18,20]. Wood et al. [20,21]
synthesized an alkyl-diacyl plasmalogen precursor with
palmitic acid at sn-1, DHA at sn-2 and lipoic acid at sn-
3 (PPI-1011). They reported that PPI-1011 replenished
PlsEtn of cultured lymphocytes from RCDP patients
[20], and the oral administration of PPI-1011 to rabbits
for 2 weeks increased DHA and DHA-containing PlsEtn
in plasma and retina [21].
The PlsEtn diet to ZDF rats increased relative compo-
sition of PlsEtn of erythrocyte membranes within
4 weeks, and the same diet to normal rats for 9 weeks
also increased relative composition of PlsEtn of the ery-
throcytes. The present study indicates that dietary PlsEtn
is safe for health of normal rats despite the decrease of
plasma phospholipids. Oral administration of purified
plasmalogens may be more efficient for replenishment
and/or replacement of plasmalogens of tissues than that
of alkyl glycerols or alkyl-diacyl plasmalogen precursor
(PPI-1011), because administration of plasmalogen may
supply glycerol with vinyl ether bond, ethanolamine,
choline and polyunsaturated fatty acids such as DHA
and ARA, all of these substances may be re-used to bio-
synthesis of plasmalogens at various tissues.
Recently, we reported that pre-treatment with the
purified plasmalogen from chicken breast muscle (com-
posed 47.6% PlsEtn and 49.3% PlsCho) by intraperitoneal
administration attenuate lipopolysaccharide-induced
neuroinflammation [22]. However, whether dietary plas-
malogens increase plasmalogen content of brain with
plasmalogen deficiency remain to be tested.
Materials and methods
Preparation of purified plasmalogens
Plasmalogens were prepared from chicken skin. The
chicken skin was obtained from a market place. Most of
fat of the chicken skin was initially removed by a steam
oven, then, the skin was freeze dried. Plasmalogens were
Figure 3 A representative HPLC chromatogram of plasma phospholipids in Wistar rat. Plasmalogens (PlsEtn and PlsCho) in rat plasma
were detected by our method (A), but they were too small to evaluate the changes of these plasmalogens even though chromatograph was
magnified (B). LPC, lysophosphatidylcholine; the other abbreviations, see Figure 1.
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cedure as reported previously [23].Table 5 Changes in plasma cholesterol and phospholipid






Total chol (mg/100mL) 98.4 ± 15.6 81.1 ± 10.2 p < 0.05Animals and diets
Diet containing 0.1 weight % purified plasmalogens
(PlsEtn diet) was prepared by supplementation of the
purified plasmalogens to control diet (AIN 96). These
diets were prepared and supplied by Oriental Yeast Co
(Tokyo, Japan).
All of the experiments involving the use of animals
were accorded to the Guiding Principles for the Care
and Use of Animals of the Physiological Society of Japan,
and all efforts were made to minimize animal suffering
and the number of animals used for the experiments.Table 4 Changes in erythrocyte phospholipid
composition of ZDF rats after the PlsEtn diet for 4 weeks
Control diet (n = 10) PlsEtn diet (n = 10) t-test
PlsEtn 14.58 ± 0.76 15.65 ± 0.75 p < 0.006
PE 7.94 ± 0.54 8.82 ± 0.58 p < 0.003
PlsCho 0.39 ± 0.08 0.43 ± 0.07
PC 62.69 ± 2.76 59.74 ± 1.53 P < 0.001
PS 4.21 ± 1.04 4.66 ± 0.47
PI 0.91 ± 0.21 1.04 ± 0.15
SM 9.27 ± 0.63 9.66 ± 0.52
Data are % of total phospholipids calculated from chromatographic area
detected by ELSD (mean ± SD).All rats were obtained from KBT Oriental Co. (Tosu
City, Saga Prefecture, Japan). Twenty male rats of ZDF
rats, aged 4 weeks, received the control diet for 10 days,
and they were divided into two groups at random. One
group (10 rats) was fed the control diet for an additional
4 weeks (control diet group), and the other groups
(10 rats) was fed the PlsEtn diet (PlsEtn diet group) for
4 weeks. In another experiment, 18 male rats of WistarHDL-chol (mg/100mL) 53.6 ± 11.3 43.9 ± 7.8 p < 0.07
LDL-chol (mg/100mL) 22.1 ± 7.3 16.6 ± 5.5 p < 0.10
TG (mg/100mL) 145.1 ± 76.7 156.5 ± 73.7
P-lipid (mg/100mL) 183.3 ± 22.9 152.7 ± 17.3 p < 0.01
Glucose (mg/100mL) 232.7 ± 36.8 220.9 ± 36.7
Urea N (mg/100mL) 12.9 ± 1.9 13.1 ± 1.3
AST (IU/L) 51.8 ± 4.3 53.4 ± 4.9
ALT (IU/L) 24.9 ± 3.6 23.3 ± 3.7
Albumin (g/100mL) 4.4 ± 0.2 4.3 ± 0.4
Body weight (g) 478.8 ± 19.1 453.6 ± 21.5
Abbreviations: chol, cholesterol; HDL, high density lipoprotein; LDL, low
density lipoprotein; TG, triacylglycerol; P-lipid, phospholipid; Urea N, urea
nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase. Data
are mean ± SD.
Table 6 Plasma phospholipid composition of Wistar rats
after the PlsEtn diet for 9 weeks
Control diet (n = 8) PlsEtn diet (n = 8)
PlsEtn 0.36 ± 0.18 0.41 ± 0.23
PE 0.34 ± 0.15 0.38 ± 0.17
PlsCho 0.43 ± 0.11 0.39 ± 0.05
PC 80.11 ± 1.24 79.95 ± 1.49
SM 5.78 ± 0.81 6.46 ± 1.65
PI 3.03 ± 0.29 2.63 ± 0.33
LPC 9.89 ± 0.84 9.73 ± 1.11
Data are % of total phospholipids calculated from chromatographic area
detected by ELSD (mean ± SD).
Table 8 Fatty acid composition of erythrocyte
phospholipids of Wistar rats after the PlsEtn diet for 9
weeks
Fatty acid Control diet PlsEtn diet t-test
[A] Fatty acid composition of erythrocyte PlsEtn + PE
22:6 + 14:0 5.46 ± 0.52 5.70 ± 0.38
20:4 30.67 ± 4.89 35.06 ± 2.91 p < 0.05
18:2 10.21 ± 1.26 10.33 ± 0.50
18:1 18.53 ± 2.29 17.69 ± 1.94
16:0 23.17 ± 2.68 20.87 ± 1.60 p < 0.06
18:0 10.05 ± 2.13 8.02 ± 1.49 p < 0.05
other 1.92 ± 0.44 2.33 ± 0.81
[B] Fatty acid composition of erythrocyte PC
22:6 + 14:0 2.32 ± 0.41 2.41 ± 0.32
20:4 8.63 ± 2.89 11.01 ± 1.71 p < 0.07
18:2 10.12 ± 1.12 11.76 ± 0.94
18:1 11.63 ± 0.73 11.58 ± 0.47
16:0 48.81 ± 3.44 45.64 ± 3.07 p < 0.07
18:0 16.21 ± 1.08 15.33 ± 1.30
other 2.28 ± 0.41 2.29 ± 0.47
Data are % of total fatty acids (mean ± SD).
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10 days, and divided into two groups. One group
received the control diet for additional 9 weeks (control
diet group) and the other group received the PlsEtn diet
for 9 weeks. All rats were housed in stainless steel wire
cages in a air conditioned room (22°C) with 12 hour
cycle of light and dark. They had free access to water
and the diets.
Preparation of erythrocytes
The rats were deprived of food for 14 to 16 hours, and,
after ether anesthesia, blood was collected into tube con-
taining EDTA by cardiac puncture. Blood plasma was
separated by centrifugation at 1000 x g for 5 min. Ery-
throcytes were prepared after the collection of plasma.
After removing the buffy coats and small portion of
top layer of erythrocytes, the erythrocytes were washed
three times in cold isotonic saline at 1000 g for 5 min at
4°C. A small portion of the top layer was removed at
each washing.
Biochemical analysis of plasma
A part of the plasma was sent to a clinical laboratory
center (CRC Co, Fukuoka, Japan) and routine clinical la-
boratory tests of plasma including plasma phosholipid
were done using an automated analyzer (Olympus AU-Table 7 Change in erythrocyte phospholipids of Wistar
rats after the PlsEtn diet for 9 weeks
Control diet (n = 8) PlsEtn diet (n = 8) t-test
PlsEtn 15.76 ± 0.78 16.61 ± 0.83 p < 0.03
PE 8.45 ± 0.71 8.35 ± 0.49
PlsCho 0.52 ± 0.12 0.51 ± 0.09
PC 57.91 ± 2.04 56.71 ± 0.91 p < 0.08
PS 4.81 ± 0.92 4.91 ± 0.99
PI 1.11 ± 0.21 1.21 ± 0.37
SM 10.32 ± 1.09 10.64 ± 0.62
Data are % of total phospholipids calculated from chromatographic area
detected by ELSD (mean ± SD).5200), in which total cholesterol, total phospholipid and
triacylglycerol were determined by each enzymatic
method (Cholsterol-C test, Phospholipid-B test and
Triglyceride-G test, Wako Pure Chemical Co Osaka,
Japan).
Extraction of total lipids
Extraction of total lipids from erythrocytes was done im-
mediately after the preparation of the washed erythro-
cytes [8,23,24]. Briefly 500 μL of the packed erythrocytes
was hemolyzed with equal volume of water. Four mL of
methanol was added to lysate followed after 40 min by
4 mL chloroform. After an additional 30 min, the extract
was centrifuged and residue was re-extracted with 4 mL
of chloroform/methanol (1:1). Pooled extracts were
washed with 10 mL 0.88% KCl to make biphasic mix-
ture. Two mL of lower phase was dried under N2 gas.
Extraction of total lipid from plasma (500 μL) was also
accorded to that from the erythrocytes. Methanol and
chloroform used in the extraction of lipids contained
butylhydroxytoluene (50 mg/L).
Separation of phospholipid classes
Separation of phospholipid classes including plasmalo-
gens (Pls) was done by our reported method [8]. The
HPLC system used was an Agilent HPLC system (HP-
1100 Series, Agilent Technologies, Tokyo, Japan)
equipped with an evaporative light scattering detector
(ELSD), a fluorescence detector and a UV dector. The
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nology) for control and analysis of chromatograms. Rela-
tive composition of phospholipid classes were measured
on each chromatographic area with ELSD detection.
Analysis of fatty acid composition of phospholipids
Each phospholipid was collected from an HPLC with
UV detection [23,24], and analysis of fatty acid compos-
ition of phospholipids was accorded to our previous
reports [23,24].
Data analysis
Data were analyzed by using a paired t test (two tailed)
with p < 0.05 used for significance.
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